Literature DB >> 8837715

Characterization of six mutations in exon 37 of neurofibromatosis type 1 gene.

M Upadhyaya1, M Osborn, J Maynard, P Harper.   

Abstract

Neurofibromatosis type 1 (NF1) is one of the most common inherited disorders, with an incidence of 1 in 3,000. We screened a total of 320 unrelated NF1 patients for mutations in exon 37 of the NF1 gene. Six independent mutations were identified, of which three are novel, and these include a recurrent nonsense mutation identified in 2 unrelated patients at codon 2281 (G2281X), a 1-bp insertion (6791 ins A) resulting in a change of TAG (tyrosine) to a TAA (stop codon), and a 3-bp deletion (6839 del TAC) which generated a frameshift. Another recurrent nonsense mutation, Y2264X, which was detected in 2 unrelated patients in this study, was also previously reported in 2 NF1 individuals. All the mutations were identified within a contiguous 49-bp sequence. Further studies are warranted to support the notion that this region of the gene contains highly mutable sequences.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8837715     DOI: 10.1002/(SICI)1096-8628(19960726)67:4<421::AID-AJMG20>3.0.CO;2-K

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  9 in total

1.  Quantification of splice variants using real-time PCR.

Authors:  I I Vandenbroucke; J Vandesompele; A D Paepe; L Messiaen
Journal:  Nucleic Acids Res       Date:  2001-07-01       Impact factor: 16.971

2.  Four frameshift mutations in neurofibromatosis type 1 caused by small insertions.

Authors:  S D Colman; C R Abernathy; V T Ho; M R Wallace
Journal:  J Med Genet       Date:  1997-07       Impact factor: 6.318

3.  Gastric carcinoid: germline and somatic mutation of the neurofibromatosis type 1 gene.

Authors:  W Stewart; J P Traynor; A Cooke; S Griffiths; N F Onen; M Balsitis; A A Shah; M Upadhyaya; E S Tobias
Journal:  Fam Cancer       Date:  2007       Impact factor: 2.375

4.  A clinical study of type 1 neurofibromatosis in north west England.

Authors:  J M McGaughran; D I Harris; D Donnai; D Teare; R MacLeod; R Westerbeek; H Kingston; M Super; R Harris; D G Evans
Journal:  J Med Genet       Date:  1999-03       Impact factor: 6.318

5.  The reduced osteogenic potential of Nf1-deficient osteoprogenitors is EGFR-independent.

Authors:  S E Tahaei; G Couasnay; Y Ma; N Paria; J Gu; B F Lemoine; X Wang; J J Rios; F Elefteriou
Journal:  Bone       Date:  2017-10-12       Impact factor: 4.398

6.  Vascular rupture-a rare lethal complication of neurofibromatosis v. Recklinghausen.

Authors:  M Kettner; P Schmidt; S A Padosch
Journal:  Forensic Sci Med Pathol       Date:  2007-10-02       Impact factor: 2.007

7.  Neurofibromatosis type 1 (NF1): a protein truncation assay yielding identification of mutations in 73% of patients.

Authors:  V M Park; E K Pivnick
Journal:  J Med Genet       Date:  1998-10       Impact factor: 6.318

8.  Identification and characterization of NF1 splicing mutations in Korean patients with neurofibromatosis type 1.

Authors:  Mi-Ae Jang; Young-Eun Kim; Sun Kyung Kim; Myoung-Keun Lee; Jong-Won Kim; Chang-Seok Ki
Journal:  J Hum Genet       Date:  2016-04-14       Impact factor: 3.172

9.  Mutational spectrum of NF1 gene in 24 unrelated Egyptian families with neurofibromatosis type 1.

Authors:  Nahla N Abdel-Aziz; Ghada Y El-Kamah; Rabab A Khairat; Hanan R Mohamed; Yehia Z Gad; Akmal M El-Ghor; Khalda S Amr
Journal:  Mol Genet Genomic Med       Date:  2021-06-03       Impact factor: 2.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.